影响肝细胞癌预后的炎症免疫细胞研究进展  

Progress of inflammatory immune cells affecting the prognosis of hepatoceHular carcinoma

作　　者：唐涛[1] 廖锐 李静[1] 杨志明[1] 

机构地区：[1]成都医学院第一附属医院肝胆外科,610500

出　　处：《中国综合临床》2018年第1期82-85,共4页Clinical Medicine of China

基　　金：国家自然科学基金（81301656）

摘　　要：炎症与肿瘤的关系一直以来都是医学研究的重点方向，炎症细胞的浸润始终伴随着恶性肿瘤的演变过程。诸多炎症细胞与肿瘤细胞之间相互诱生而导致一种炎症级联瀑布反应并逐渐形成炎症肿瘤免疫网络，其不仅参与肿瘤的发生、发展，也影响患者预后。近年来临床研究证实通过检测外周血相关炎症免疫细胞可以准确预测肝细胞癌的预后。我们收集国内外相关资料，对影响肝细胞癌预后的炎症免疫细胞作一综述。The relationship between inflammation and cancer has long been the focus of the medical research direction, the infiltration of inflammatory cells is always accompanied by the evolution process of malignant tumor,a lot of inflammatory cells and tumor cells are mutually induced, and lead to a inflammation cascade reaction, finally gradually form an immune network of inflammatory tumor, which not only involves in the occurrence and development of tumor, but also affects the prognosis of patients. In recent years, clinical studies have confirmed that the detection of peripheral blood related inflammatory immune cells can accurately predict the prognosis of hepatocellular carcinoma. Based on the collection of related information at home and abroad, a summary was made to clarify the effects of inflammatory immune cells on the prognosis of hepatocellular

关 键 词：肝细胞癌 慢性炎症 单核细胞 淋巴细胞 中性粒细胞 

分 类 号：R735.7[医药卫生—肿瘤]